Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Ten Years of Screening and Testing for Acute HIV Infection in North Carolina.

Kuruc JD, Cope AB, Sampson LA, Gay CL, Ashby RM, Foust EM, Brinson M, Barnhart JE, Margolis D, Miller WC, Leone PA, Eron JJ.

J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):111-9. doi: 10.1097/QAI.0000000000000818.

PMID:
26761274
2.

Costs per Diagnosis of Acute HIV Infection in Community-based Screening Strategies: A Comparative Analysis of Four Screening Algorithms.

Hoenigl M, Graff-Zivin J, Little SJ.

Clin Infect Dis. 2016 Feb 15;62(4):501-11. doi: 10.1093/cid/civ912. Epub 2015 Oct 27.

PMID:
26508512
3.

The HIV treatment cascade in acutely infected people: informing global guidelines.

Rutstein SE, Sellers CJ, Ananworanich J, Cohen MS.

Curr Opin HIV AIDS. 2015 Nov;10(6):395-402. doi: 10.1097/COH.0000000000000193.

PMID:
26371460
4.

Ongoing HIV Transmission and the HIV Care Continuum in North Carolina.

Cope AB, Powers KA, Kuruc JD, Leone PA, Anderson JA, Ping LH, Kincer LP, Swanstrom R, Mobley VL, Foust E, Gay CL, Eron JJ, Cohen MS, Miller WC.

PLoS One. 2015 Jun 4;10(6):e0127950. doi: 10.1371/journal.pone.0127950. eCollection 2015.

5.

How can we better identify early HIV infections?

Rosenberg NE, Pilcher CD, Busch MP, Cohen MS.

Curr Opin HIV AIDS. 2015 Jan;10(1):61-8. doi: 10.1097/COH.0000000000000121. Review.

6.

Screening for acute HIV infections and estimating HIV incidence among female sex workers from low-grade venues in Guangxi, China.

Li J, Zhang H, Shen Z, Zhou Y, Fang N, Wang L, Wang B, Wang J, Tang Z.

PLoS One. 2014 Jun 11;9(6):e99522. doi: 10.1371/journal.pone.0099522. eCollection 2014.

7.

Advances and challenges in biosensor-based diagnosis of infectious diseases.

Sin ML, Mach KE, Wong PK, Liao JC.

Expert Rev Mol Diagn. 2014 Mar;14(2):225-44. doi: 10.1586/14737159.2014.888313. Epub 2014 Feb 13. Review.

8.

Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco.

Pilcher CD, Louie B, Facente S, Keating S, Hackett J Jr, Vallari A, Hall C, Dowling T, Busch MP, Klausner JD, Hecht FM, Liska S, Pandori MW.

PLoS One. 2013 Dec 12;8(12):e80629. doi: 10.1371/journal.pone.0080629. eCollection 2013.

9.

Finding those at risk: acute HIV infection in Newark, NJ.

Martin EG, Salaru G, Mohammed D, Coombs RW, Paul SM, Cadoff EM.

J Clin Virol. 2013 Dec;58 Suppl 1:e24-8. doi: 10.1016/j.jcv.2013.07.016. Epub 2013 Aug 13.

10.

Community viral load as a measure for assessment of HIV treatment as prevention.

Miller WC, Powers KA, Smith MK, Cohen MS.

Lancet Infect Dis. 2013 May;13(5):459-64. doi: 10.1016/S1473-3099(12)70314-6. Epub 2013 Mar 25.

11.

Acute on-chip HIV detection through label-free electrical sensing of viral nano-lysate.

Shafiee H, Jahangir M, Inci F, Wang S, Willenbrecht RB, Giguel FF, Tsibris AM, Kuritzkes DR, Demirci U.

Small. 2013 Aug 12;9(15):2553-63, 2478. doi: 10.1002/smll.201202195. Epub 2013 Feb 27.

12.

Leveraging a rapid, round-the-clock HIV testing system to screen for acute HIV infection in a large urban public medical center.

Christopoulos KA, Zetola NM, Klausner JD, Haller B, Louie B, Hare CB, Pandori M, Nassos P, Roemer M, Pilcher CD.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):e30-8. doi: 10.1097/QAI.0b013e31827a0b0d.

13.

HIV nucleic acid amplification testing versus rapid testing: it is worth the wait. Testing preferences of men who have sex with men.

O'Neal JD, Golden MR, Branson BM, Stekler JD.

J Acquir Immune Defic Syndr. 2012 Aug 1;60(4):e117-20. doi: 10.1097/QAI.0b013e31825aab51. No abstract available.

14.

Integrating acute HIV infection within routine public health surveillance practices in New York City.

Bodach S, Braunstein S, Bernard MA, Sabharwal CJ, Tsega A, Shepard C.

Public Health Rep. 2012 Jul-Aug;127(4):451-9. No abstract available.

15.

Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group.

Stekler JD, Wellman R, Holte S, Maenza J, Stevens CE, Corey L, Collier AC.

Int J STD AIDS. 2012 Mar;23(3):201-6. doi: 10.1258/ijsa.2011.011178.

16.

Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection.

Karris MY, Anderson CM, Morris SR, Smith DM, Little SJ.

J Clin Microbiol. 2012 Jun;50(6):1874-8. doi: 10.1128/JCM.00106-12. Epub 2012 Mar 21.

17.

Screening acute HIV infections among Chinese men who have sex with men from voluntary counseling & testing centers.

Han X, Xu J, Chu Z, Dai D, Lu C, Wang X, Zhao L, Zhang C, Ji Y, Zhang H, Shang H.

PLoS One. 2011;6(12):e28792. doi: 10.1371/journal.pone.0028792. Epub 2011 Dec 14.

18.
19.

Acute hepatitis C virus in an HIV clinic: a screening strategy, risk factors, and perception of risk.

Taylor LE, DeLong AK, Maynard MA, Chapman S, Gholam P, Blackard JT, Rich J, Mayer KH.

AIDS Patient Care STDS. 2011 Oct;25(10):571-7. doi: 10.1089/apc.2011.0106. Epub 2011 Aug 22.

20.

Performance of risk-based criteria for targeting acute HIV screening in San Francisco.

Facente SN, Pilcher CD, Hartogensis WE, Klausner JD, Philip SS, Louie B, Christopoulos KA, Dowling T, Colfax GN.

PLoS One. 2011;6(7):e21813. doi: 10.1371/journal.pone.0021813. Epub 2011 Jul 6.

Items per page

Supplemental Content

Write to the Help Desk